1Kahn R, Buse J, Ferrannini E, et al. The metabolic syndrome: time for a critical appraisal, joint statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care, 2005, 28 (9) : 2289 - 2304.
2Basson B, Kinon B, Taylor C, et al. Factors influencing weight change in patients with schizophrenia treated with olanzapine versus haloperidol or risperidone. J Clin Psychiat, 2001, 62(4): 231 - 238.
3Poyurovsky M, lsaacs I, Fuchs C, et al. Attenuation of olanzapine - induced weight gain with reboxetine in patients with schizophrenia: a double - blind, placebo - controlled study. Am J Psychiat, 2003, 160 (2) : 297 - 302.
4Allison D, Mentore J, Heo M, et al. Antipsychotic - induced weight gain: a comprehensive research synthesis. Am J Psychiat, 1999, 156 ( 11 ) : 1686 - 1696.
5Lieberman J, Stroup T, McEvoy J, et al. Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. N Eng J Med, 2005, 353(12) : 1209 -1223.
6McEvoy J, Lieberman J, Perkins D, et al. Efficacy and tolerability of olanzapine, quetiapine, and risperidone in the treatment of early psychosis: a randomized, double - blind 52 - week comparison. Am J Psychiat, 2007, 164(7) : 1050 - 1060.
7Breier A, Berg P, Thakore J, et al. Olanzapine versus ziprasidone: results of a 28 - week douhle - hlind study in patients with schizophrenia. Am J Psychiat, 2005, 162(10) : 1879 -1887.
8Kinon B, Lipkovich I, Edwards S, et al. A 24 - week randomized study of olanzapine versus ziprasidone in the treatment of schizophrenia or schizoaffective disorder in patients with prominent depressive symptoms. J Clin Psychopharmacol, 2006, 26(2) : 157 -162.
9Simpson G, Glick I, Weiden P, et al. Randomized, controlled, double - blind multicenter comparison of the efficacy and tolerability of ziprasidone and olanzapine in acutely ill inpatients with schizophrenia or schizoaffective disorder. Am J Psychiat, 2004, 161 (10) : 1837 - 1847.
10Su K, Wu P, Pariante C. A crossover study on lipid and weight changes associated with olanzapine and risperidone. Psychopharmacol, 2005, 183(3) : 383 -386.
